In addition to the anti-inflammatory effect of anti-TNF-α therapy, and the consequential improvement in joint function, they may indirectly lead to increased levels of physical activity, which will subsequently decrease the incidence of other CV risk factors, such as diabetes mellitus and hypertension [114]. The gene discussed is TNF; the disease is diabetes mellitus.